Mantle cell lymphoma: open trials in Australia

13 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT06084936
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Trial Treatment · Phase 3 · Hoffmann-La Roche
Royal Adelaide Hospital, Adelaide · Epworth Hospital, Richmond · Calvary Mater Newcastle, Waratah
Registry updated 2026-11-05
NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
The Alfred Hospital, Melbourne, VIC · Linear Clinical Research, Nedlands
Registry updated 2026-11-04
NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
Royal Adelaide Hospital, Adelaide · Royal Hobart Hospital, Hobart · Linear Clinical Research, Perth · Westmead Hospital, Westmead
Registry updated 2026-11-03
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Monash Health, Clayton · Austin Health, Melbourne · Linear Clinical Research, Nedlands · Gold Coast Hospital, Southport
Registry updated 2026-11-02
NCT06742996
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Trial Treatment · Phase 3 · BeOne Medicines
Sunshine Coast Hospital and Health Service, Birtinya · Box Hill Hospital, Box Hill · Monash Health, Clayton · Rockingham Hospital, Cooloongup · Perth Blood Institute, West Perth
Registry updated 2026-10-29
NCT06564038
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Heidelberg · Melbourne · Nedlands
Registry updated 2026-10-28
NCT06697184
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Trial Treatment · Phase 1/2 · BeOne Medicines
GenesisCare - St Andrews, Adelaide · Blacktown Cancer and Haematology Centre, Blacktown · Rockingham Hospital, Cooloongup · Cabrini Hospital - Malvern, Malvern · The Alfred Hospital, Melbourne · Linear Clinical Research, Nedlands
Registry updated 2026-10-26
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Concord Repatriation General Hospital, Concord · St Vincents Hospital Melbourne, Fitzroy · Austin Health, Heidelberg · Peter MacCallum Cancer Centre, Melbourne · The Alfred Hospital, Melbourne · Linear Clinical Research, Nedlands · Calvary Mater Newcastle, Waratah · Perth Blood Institute, West Perth · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-10-05
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Melbourne · Nedlands
Registry updated 2026-09-30
NCT06022029
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Trial Treatment · Phase 1 · OncoNano Medicine, Inc.
Southern Oncology Clinical Research Unit, Bedford Park · University of the Sunshine Coast Clinical Trials, Buderim · St Vincent's Hospital, Darlinghurst · Tasman Oncology Research, Southport · St. John of God Subiaco Hospital, Subiaco · Cancer Care Wollongong, Wollongong · Princess Alexandra Hospital | Metro South Health, Woolloongabba
Registry updated 2025-12-24
NCT05643742
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Trial Treatment · Phase 1/2 · CRISPR Therapeutics AG
Royal Prince Alfred, Camperdown · Alfred Health, Melbourne · Sir Charles Gairdner Hospital, Nedlands
Registry updated 2025-11-14
NCT05659732
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
Trial Treatment · Phase 1 · PharmaEngine
Monash Medical Centre, Clayton
Registry updated 2025-07-31
NCT05833763
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Trial Treatment · Phase 2 · Australasian Leukaemia and Lymphoma Group
Sir Charles Gairdener, Nedlands · Peter MacCallum Cancer Centre, Parkville
Registry updated 2024-01-08

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error